Literature DB >> 656844

Dopamine and dobutamine.

A Yates.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 656844      PMCID: PMC1605397          DOI: 10.1136/bmj.1.6127.1622

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  Pedal gangrene associated with the use of dopamine.

Authors:  C S Alexander; Y Sako; E Mikulic
Journal:  N Engl J Med       Date:  1975-09-18       Impact factor: 91.245

2.  Letter: Dopamine gangrene.

Authors:  S I Greene; J W Smith
Journal:  N Engl J Med       Date:  1976-01-08       Impact factor: 91.245

3.  In vivo analysis of adrenergic receptor activity of dobutamine.

Authors:  N W Robie; D O Nutter; C Moody; J L McNay
Journal:  Circ Res       Date:  1974-05       Impact factor: 17.367

4.  Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.

Authors:  H S Loeb; J Bredakis; R M Gunner
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

5.  Comparison of dobutamine and dopamine in treatment of severe heart failure.

Authors:  J D Stoner; J L Bolen; D C Harrison
Journal:  Br Heart J       Date:  1977-05

6.  Effects of dobutamine in patients with acute myocardial infarction.

Authors:  T A Gillespie; H D Ambos; B E Sobel; R Roberts
Journal:  Am J Cardiol       Date:  1977-04       Impact factor: 2.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.